The Inequality of Science

FEATUREThe Inequality of Science   © JOELLE BOLTIn 2004, close to one in five extramural NIH dollars went to only 10 of the 3,000 institutions that received grants. Five US states get almost half of all funding. What about everyone else? BY ALISON MCCOOKThe ceiling in the medical school at the University of South Dakota (USD) in Vermillion is visibly water-stained and falling down in spots. Walking through the fac

Written byAlison McCook
| 14 min read

Register for free to listen to this article
Listen with Speechify
0:00
14:00
Share

In 2004, close to one in five extramural NIH dollars went to only 10 of the 3,000 institutions that received grants. Five US states get almost half of all funding. What about everyone else?
BY ALISON MCCOOK

The ceiling in the medical school at the University of South Dakota (USD) in Vermillion is visibly water-stained and falling down in spots. Walking through the facility, researcher Robin Miskimins admits that she can't plug in two hoods and three incubators in the tissue culture room without blowing a circuit. Everyone shares key equipment, such as a confocal microscope, a cell culture facility, and an aging scanning electron microscope.

Four hundred miles due north through largely farm country, Diane Darland waited for months after moving from Boston to the University of North Dakota (UND) in Grand Forks to get equipment - a small set of cages for transgenic mice, and a $10,000 hood ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies